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Level 1 STEMI PTs w/angiogram, N=2062
Death w/CTO N¼297 w/o CTO N¼1765 p-value
In-Hospital Death, N (%) 39 (13.1) 63 (3.6) <0.0001
Death in 30 days, N (%) 45 (15.2) 75 (4.3) <0.0001
Death in 1 year, N (%) 65 (21.9) 133 (7.5) <0.0001
Level 2 NSTEACS PTs w/angiogram, N=827
Death w/CTO N¼203 w/o CTO N¼624 p-value
In-Hospital Death, N (%) 11 (5.4) 10 (1.6) 0.0027
Death in 30 days, N (%) 14 (6.9) 13 (2.1) 0.0008
Death in 1 year, N (%)* 11 (9.5) 25 (6.4) 0.2647
*N¼504 for 1 year (excluding 2012)
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hospital, 30 day, and one year mortalities than STEMI PTs without a CTO. PTs with
NSTEACS and a CTO have higher in-hospital and 30 day mortality than NSTEACS
PTs without a CTO, and there is a non-signiﬁcant trend towards increased one year
mortality for PTs with a CTO. Strategies to reduce this increased mortality are needed.
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Background: Cardiac arrest (CA) is often the result of both acute and chronic
coronary artery disease (CAD) particularly when it is caused by ventricular tachy-
cardia or ﬁbrillation (VT/VF). Therapeutic hypothermia has been shown to decrease
mortality and after resuscitated CA (rCA). It has been demonstrated that a chronic
total occlusion (CTO) in the non-infarct artery in patients (Pts) with ST segment
elevation myocardial infarction (STEMI) is associated with increased mortality.
The incidence and effect of CTOs in Pts with rCA has not been well described.
Further the incidence and effect of CTOs in rCA Pts as the result of STEMI is
unknown.
Methods: The Minneapolis Heart Institute has developed formalized protocols for both
STEMI (Level One, L1) and cardiac arrest and sequential therapeutic hypothermia (Cool-
It). From 2006-May 2012, 164 sequential Pts who had been enrolled in the Cool-It
program who presented with VT/VF and underwent angiography were evaluated for the
presence of at least one CTO in a major coronary vessel. From 2006-May 2012, 121 PTs
who had been enrolled in the Cool-It program and underwent angiography but also
suffered from STEMI were also evaluated for CTOs. In-hospital, 30 day, and 1 year
mortality were compared between Pts who did and did not have CTO. STEMI Pts who
presented with rCAwere compared to STEMI Pts without rCA for the presence of a CTO.
Results: See table below:Cool-It Pts w/angiogram and VT/VF, N=164
Death w/CTO N¼37 w/o CTO N¼127 p-value
In-Hospital Death, N (%) 15 (40.5) 37 (29.1) 0.1895
Death in 30 days, N (%) 16 (43.2) 40 (31.5) 0.1848
Death in 1 year, N (%) 17 (46.0) 43 (33.9) 0.1792
Cool-It Pts w/angiogram and STEMI, N¼121
Death w/CTO N¼30 w/o CTO N¼91 p-value
In-Hospital Death, N (%) 16 (53.3) 33 (36.3) 0.0986
Death in 30 days, N (%) 15 (50) 35 (38.5) 0.2657
Death in 1 year, N (%) 17 (56.7) 37 (40.7) 0.1261
STEMI Pts from 2007-2011, N=2062
w/rCA w/o rCA p-value
w/CTO, N (% for column) 22 (24.7) 275 (13.9) 0.0046
w/o CTO, N (% for column) 67 (75.3) 1698 (86.1)Conclusions: These data demonstrate that rCA Pts presenting with VT/VF and who
have a CTO appear to have similar mortality compared to those without a CTO. Pts
with and without a CTO who presented with rCA and STEMI have similar mortality
although there is a trend in favor of those without a CTO. STEMI Pts with rCA have
a higher incidence of a CTO than do STEMI Pts without rCA. Further efforts to
understand, treat, and avoid CA in Pts with a CTO are warranted.JACC Vol 62/18S1/Suppl B j October 27–November 1, 2013 j TCT AbTCT-372
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Background: Limiteddata exists onpatientswhohaveundergonedrug eluting stent (DES)
implantation of long chronic total occlusive (CTO) lesion in native coronary arteries.
Methods:Wedeﬁned longcontinuousstent implantation (stent length> or¼ 50mm)as"full
metal jacket" (FMJ). FromApril 2007 toMarch 2013, 344 consecutive patients (361 lesions)
who underwent FMJ using any DESs for de novo lesion were enrolled. Subjects were clas-
siﬁed into twogroups: thepatientswithCTOlesion (CTOgroup,113patients, 114 lesions) and
without CTO lesion (non-CTO group, 239 patients, 247 lesions). The two groups were
compared for mean 2419 months clinical outcomes. Endpoints were freedom from target
lesion revascularization (TLR) and major adverse cardiovascular events (MACE) deﬁned as
composite of TLR, myocardial infarction and all cause death at 5 years after percutaneous
coronary interventionprocedure.Thiswas a single center non-randomized retrospective study.
Results: CTOgroupwas younger than non-CTOgroup (66.00.9 vs. 70.00.6, p<0.05).
The percentage of male gender and hyperlipidemia were higher in CTO group than non-
CTO group (84.2% vs. 69.6%, p<0.05 and 58.8% vs. 47.0%, p<0.05, respectively). There
were no signiﬁcant differences between both study arms in percentages of diabetes mellitus
(43.0% vs. 48.6%, p¼0.32), hypertension (71.9% vs. 75.2%, p¼0.51), hemodialysis (2.6%
vs. 5.3%, p¼0.26) and current smoker (19.3% vs. 17.1%). Target vessel wasmore often the
right coronary artery in CTO group than non-CTO group (71.1% vs. 33.2%, p<0.05). The
mean total length of implanted stents was longer in CTO group than non-CTO group
(72.81.4mmvs. 60.90.9mm,p<0.05). Intravascular ultrasoundwas used in 70.0% and
follow up rate of angiographywas 75.9%. Regarding the long-term clinical outcomes, there
were no signiﬁcant differences in the rate of freedom from TLR (60.510.5% vs.
76.94.7%, Log rank p¼0.48) andMACE (53.89.9%vs. 67.24.8%,Log rank p¼0.88)
at 5 years estimated using the Kaplan-Meier methods compared to non-CTO group.
Conclusions: The strategy of FMJ using DES was acceptable for CTO lesions.
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Background: The use of retrograde approach for recanalization of chronic total occlusion
(CTO) has been established with improved success rates. During the procedure of percuta-
neous coronary intervention (PCI) for CTO lesions in the retrograde approach, electrocar-
diographic R-wave amplitudes often decrease in many leads. Because the differential
diagnoses of low voltages on electrocardiogram (ECG) include pericardial effusion, the
presence of these changes should increase the index of suspicion for a signiﬁcant pericardial
effusiondue to coronaryperforation andprompt further evaluation suchas echocardiography.
Methods: We analyzed the recent 30 patients (group-R, age 6512) who underwent
successful PCI for CTO lesions in the retrograde approach and the recent 30
patients (group-E, age 6010) who underwent treatment for pericardial effusion
during catheter intervention. Group-E was divided into 2 groups according to whether
requiring drainage of effusion [group-E/D(+) ,n¼15] or not [group E/D(-), n¼15].
Pre-ECG was deﬁned as the ECG just before the catheter intervention. Post-ECG was
deﬁned as the ECG just before the procedure of drainage for Group-E/D(+) and the
ECG immediately after catheter intervention for other groups.
Results: In comparison of pre-ECG and post-ECG, the leads in which R-wave
amplitude signiﬁcantly decreased were I, II, aVL, V1,V4, V5, and V6 in group-R; I,
II, aVL,V4, V5, and V6 in group-E/D(+); but only aVL in group-E/D(-). Heart rate
(HR) signiﬁcantly increased in group-E /D(+) (6412 to 8318, p¼0.0034) between
the 2 ECGs, but not in group-R and group-E/D(-). Comparing group-R and group-E/
D(+), the rate of R-wave amplitude between the 2 ECGs [(R-wave amplitude in post-
ECG)/(R-wave amplitude in pre-ECG)] was similar in all leads. But the rate of HR
between the 2 ECGs [(HR in post-ECG) / (HR in pre-ECG)] was higher in group-E/
D(+) (0.960.34 vs 1.320.29, p¼0.0024). Comparing group-R and group-E/D(-),
the rate of HR between the 2 ECGs was similar. But the rate of R-wave amplitudes
between the 2 ECGs of group-R was signiﬁcantly lower in leads I(0.660.25 vs
0.990.58, p¼0.0074), II(0.880.33 vs 1.200.41, p¼0.014), V1(0.720.29 vs
1.110.55, p¼0.0019), and V5(0.670.31 vs 0.950.30, p¼0.0042).
Conclusions: During the procedure of PCI for CTO lesions in the retrograde approach,
ECG shows decreasing R-wave amplitudes similarly with the case of pericardial effusion
requiring drainage during catheter intervention. However, by taking HR into account,
decreasingR-wave amplitude during PCI for CTO lesions in the retrograde approach could
bediscriminated fromECGchangesdue topericardial effusionduring catheter intervention.
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